Ximing Xu

Jiangsu University — China

Medicine · Health Sciences

26h-index2.1kcitations146works3.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(25), Cancer-related molecular mechanisms research(16), MicroRNA in disease regulation(14), Circular RNAs in diseases(12), Hepatocellular Carcinoma Treatment and Prognosis(11)

Publications146 total

Botanical Nanovesicles Boost Mesenchymal Stem Cell Therapy: Next-Gen Advanced Therapy Medicinal Products for Spinal Cord Injury
Tissue Engineering Part B Reviews·2026
Matrix stiffening-driven hepatocellular carcinoma progression through OASL-mediated cGAS-STING repression and subsequent macrophage activation
International Immunopharmacology·2025
Astragaloside-Soluplus/TPGS/glycyrrhizic acid ammonium salt mixed micelles: preparation and pharmacodynamic evaluation
Journal of drug targeting·2025
Risk factors and mechanisms of immune checkpoint inhibitor-related pneumonitis
Human Vaccines & Immunotherapeutics·2025· 3 citedOpen Access
Polyelectrolyte Complex-Based Artificial Biofilms as Versatile Living Biomaterials
ACS Applied Materials & Interfaces·2025· 1 cited
Finotonlimab (PD-1 inhibitor) plus bevacizumab (bevacizumab biosimilar) as first-tier therapy for late-stage hepatocellular carcinoma: a randomized phase 2/3 trial
Signal Transduction and Targeted Therapy·2025· 5 citedOpen Access
m6A-modified circCCAR1 promotes malignant proliferation by enhancing KIF5B expression in hepatocellular carcinoma
Journal of Physiology and Biochemistry·2025
A review of immune checkpoint inhibitor-associated myocarditis: Epidemiology, pathogenesis, and biomarkers
Human Vaccines & Immunotherapeutics·2025· 6 citedOpen Access
Immune Cellular Patterns Predicting Lymph Node Status Helps Personalized Management of Stage T1 Esophageal Squamous Cell Carcinoma
Modern Pathology·2025
NSMCE2 promotes the occurrence and development of HCC by regulating the SUMOylation of PPARα
International Immunopharmacology·2025· 2 citedOpen Access
AI-guided Generation and Development of HXN-1011, A Highly Potent Anti-TSLP Biparatopic Antibody
American Journal of Respiratory and Critical Care Medicine·2025· 1 cited
Bispecific Antibody Targeting Both IL33 and TSLP for Asthma and COPD
American Journal of Respiratory and Critical Care Medicine·2025· 4 cited
AI-guided Engineering and Generation of Bispecific Antibodies Targeting Both IL13 and TSLP for Chronic Respiratory Diseases
American Journal of Respiratory and Critical Care Medicine·2025· 1 cited
Intelligent Diagnosis of Cervical Lymph Node Metastasis Using a CNN Model
Journal of Dental Research·2025
Preparation of PEG-modified isoquercitrin liposomes and anti-chronic kidney disease research
Journal of Liposome Research·2025· 1 cited
Short-course radiotherapy (SCRT) followed by fruquintinib plus adebrelimab and CAPOX in the total neoadjuvant therapy of locally advanced rectal cancer (LARC): A multicenter, single-arm, open-label, phase II study (UNION TNT).
Journal of Clinical Oncology·2025
P0848 Engineering and Development of a Novel Bispecific Antibody Targeting both TL1A and α4β7 for the Treatment of IBD
Journal of Crohn s and Colitis·2025· 2 citedOpen Access
682P First-line serplulimab for advanced squamous non-small cell lung cancer: A multicenter, single-arm, real-world ASTRUM-004R study
Annals of Oncology·2024Open Access
Impact of different nephrectomy types on M0 renal cell carcinoma outcomes in a propensity score matching and deep learning study
Scientific Reports·2024Open Access
Lycium barbarum oligosaccharide-derived carbon quantum dots inhibit glial scar formation while promoting neuronal differentiation of neural stem cells
International Journal of Biological Macromolecules·2024· 3 citedOpen Access
page 1 of 8Next →

Frequent Co-authors

Wei Ge(17), Dedong Cao(11), Xiaoqin He(11), Huilin Xu(9), Yongfa Zheng(7), Yangtao Xu(7), Junjian Deng(6), Xinyao Hu(6), Jiayu Chen(5), Yang Shen(5), Hua Zhu(5), Wenliang Chen(4), Lin Xiong(4), Changhu Li(3), Yuanyuan Gan(3), Nana Han(3), Jiajun Yu(3), Yongfa Zheng(3), Xiaoyu Zhang(3), Honggang Yu(2)